20.01.2013 Views

Pharmaceuticals Sector - Solvay

Pharmaceuticals Sector - Solvay

Pharmaceuticals Sector - Solvay

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Highlights<br />

January 2005<br />

<strong>Solvay</strong> fi nalizes<br />

the sale to BP of its<br />

interests in the BP<br />

<strong>Solvay</strong> Polyethylene<br />

joint ventures,<br />

concluding a series<br />

of transactions<br />

initiated by <strong>Solvay</strong><br />

and BP in 2000.<br />

April 2005<br />

<strong>Solvay</strong> Solexis begins<br />

marketing its new grade of<br />

TECNOFLON ®<br />

perfl uorinated elastomers,<br />

created by a brand-new<br />

polymerization technology<br />

able to generate products<br />

with unequalled properties.<br />

October 2005<br />

<strong>Solvay</strong> Pharma<br />

launches its project<br />

to integrate Fournier<br />

Pharma and create<br />

the future « <strong>Solvay</strong><br />

<strong>Pharmaceuticals</strong> ».<br />

February 2005<br />

The Rigid Plastic Foils activity,<br />

comprising the two Italian plants<br />

at Monfalcone and Fucine, is sold<br />

to Ineos.<br />

Vinythaï<br />

decides to integrate upstream<br />

in the PVM and VCM (vinyl<br />

chloride monomer) chain by doubling<br />

chlorine and ethylene dichloride<br />

production capacity at its Map<br />

Ta Phut plant (Thailand).<br />

July 2005<br />

<strong>Solvay</strong> agrees to sell its entire Industrial<br />

Foils activities – development,<br />

production and marketing of plastic fi lms<br />

and foils – to Renolit AG (Germany).<br />

<strong>Solvay</strong> concludes its major<br />

stategic acquisition of<br />

100%<br />

of Fournier Pharma.<br />

November 2005<br />

<strong>Solvay</strong> and Chemical Products<br />

Corporation (CPC) of the USA create a<br />

joint venture for their technical-grade<br />

barium and<br />

strontium<br />

carbonate<br />

activities.<br />

March 2005<br />

<strong>Solvay</strong> and<br />

Fournier<br />

Pharma’s<br />

shareholders<br />

sign agreement<br />

for <strong>Solvay</strong>’s<br />

acquisition of<br />

100% of<br />

Fournier Pharma.<br />

May 2005<br />

<strong>Solvay</strong> Solexis<br />

announces two major capacity<br />

expansions for ALGOFLON ® and<br />

HYFLON ® fl uorinated polymers<br />

at Spinetta Marengo (Italy).<br />

<strong>Solvay</strong> announces creation of a<br />

joint venture in China to produce<br />

ultra-pure hydrogen peroxide.<br />

August 2005<br />

<strong>Solvay</strong> Organics GmbH successfully<br />

concludes its public offer for chemical<br />

specialties company Girindus AG,<br />

operating out of Bensberg, Germany,<br />

with a site at Cincinnati, Ohio (USA),<br />

and creates a new<br />

“Molecular Solutions”<br />

Strategic Business Unit.<br />

2005 Highlights<br />

June 2005<br />

<strong>Solvay</strong> announces<br />

plant at Onsan<br />

(South Korea) to<br />

produce inorganic<br />

fl uorinated<br />

specialties for<br />

high-growth<br />

markets.<br />

September 2005<br />

<strong>Solvay</strong> creates a Technical Centre at<br />

Shanghai,<br />

China, in response to growing<br />

demand from Chinese customers<br />

for Specialty Polymers (<strong>Solvay</strong><br />

High Performance Materials R&D<br />

(Shanghai) Co., Ltd).<br />

December 2005<br />

<strong>Solvay</strong> and Gharda (India) sign an<br />

agreement for <strong>Solvay</strong> to acquire<br />

Gharda’s plastics division, providing<br />

access to very high performance<br />

PEEK polymers and<br />

additional polysulfone capacity.<br />

<strong>Solvay</strong> signs partnership<br />

agreement with BASF and Dow<br />

for production of hydrogen<br />

peroxide to supply propylene<br />

oxide production at Antwerp<br />

(Belgium).<br />

<strong>Solvay</strong> Global Annual Report 2005<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!